| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |